Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.34
+0.51 (4.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Mineralys Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 20.65 | 14.3 | 5.23 | 2.42 | 0.53 |
| Research & Development | 147.7 | 70.36 | 26.25 | 16.31 | 2.41 |
| Operating Expenses | 168.35 | 84.66 | 31.48 | 18.73 | 2.94 |
| Operating Income | -168.35 | -84.66 | -31.48 | -18.73 | -2.94 |
| Interest Expense | - | - | - | -0.03 | -0.12 |
| Interest & Investment Income | 15.1 | 12.76 | 1.68 | - | - |
| Other Non Operating Income (Expenses) | -0.01 | 0 | 0 | 0 | -0.37 |
| EBT Excluding Unusual Items | -153.25 | -71.9 | -29.8 | -18.75 | -3.43 |
| Other Unusual Items | - | - | - | -0.66 | - |
| Pretax Income | -153.25 | -71.9 | -29.8 | -19.41 | -3.43 |
| Net Income | -153.25 | -71.9 | -29.8 | -19.41 | -3.43 |
| Net Income to Common | -153.25 | -71.9 | -29.8 | -19.41 | -3.43 |
| Shares Outstanding (Basic) | 46 | 36 | 5 | 5 | 5 |
| Shares Outstanding (Diluted) | 46 | 36 | 5 | 5 | 5 |
| Shares Change (YoY) | 67.83% | 600.33% | 3.67% | 7.64% | - |
| EPS (Basic) | -3.33 | -1.99 | -5.77 | -3.89 | -0.74 |
| EPS (Diluted) | -3.33 | -1.99 | -5.77 | -3.89 | -0.74 |
| Free Cash Flow | -128.55 | -81.17 | -29.22 | -14.56 | -2.46 |
| Free Cash Flow Per Share | -2.79 | -2.24 | -5.65 | -2.92 | -0.53 |
| EBIT | -168.35 | -84.66 | -31.48 | -18.73 | -2.94 |
Source: S&P Capital IQ. Standard template.
Financial Sources.